Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | 1 | — | — | — | 1 |
Asthma | D001249 | EFO_0000270 | J45 | — | 1 | — | — | — | 1 |
Drug common name | REVAMILAST |
INN | revamilast |
Description | Revamilast is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target 3',5'-cyclic-AMP phosphodiesterase 4A; cAMP-specific 3',5'-cyclic phosphodiesterase 4A. |
Classification | Small molecule |
Drug class | antiasthmatics/antiallergics (not acting primarily as antihistamines): type IV phosphodiesterase |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12 |
PDB | — |
CAS-ID | 893555-90-3 |
RxCUI | — |
ChEMBL ID | CHEMBL4297527 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 30LE65637T (ChemIDplus, GSRS) |